The reduced LATS2 levels detected in parathyroid adenomas are in agreement with the inhibitory effect on LATS2 expression levels exerted by miR-372, which has been found to be overexpressed in a subset of parathyroid adenomas and most parathyroid cancers [17]. Here, LATS2 is linked to malignant tumor of parathyroid gland.